ruboxistaurin has been researched along with Kidney Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Advani, A; Connelly, KA; Cox, AJ; Edgley, AJ; Gilbert, RE; Kelly, DJ; Tan, SM; Thai, K; Whiteside, CI; Zhang, Y | 1 |
Shah, SV | 1 |
Shah, SV; Swaminathan, S | 1 |
2 review(s) available for ruboxistaurin and Kidney Diseases
Article | Year |
---|---|
Progress toward novel treatments for chronic kidney disease.
Topics: Amides; Anticoagulants; Antihypertensive Agents; Bicarbonates; Chronic Disease; Enzyme Inhibitors; Fumarates; Glycosaminoglycans; Humans; Indoles; Iron Chelating Agents; Kidney Diseases; Kidney Failure, Chronic; Maleimides; Pentoxifylline; Phosphodiesterase Inhibitors; Protein Kinase C; Pyridones; Renin; Renin-Angiotensin System | 2010 |
Novel approaches targeted toward oxidative stress for the treatment of chronic kidney disease.
Topics: Biomarkers; Chronic Disease; Diabetic Nephropathies; Disease Progression; Drugs, Investigational; Glycation End Products, Advanced; Humans; Indoles; Iron; Kidney; Kidney Diseases; Maleimides; Oxidative Stress; Protein Kinase C; Protein Kinase Inhibitors; Pyridoxamine; Reactive Oxygen Species; Treatment Outcome; Vitamin B Complex | 2008 |
1 other study(ies) available for ruboxistaurin and Kidney Diseases
Article | Year |
---|---|
Protein kinase C-beta inhibition attenuates the progression of nephropathy in non-diabetic kidney disease.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Glomerular Filtration Rate; Humans; Indoles; Kidney; Kidney Diseases; Male; Maleimides; Membrane Proteins; Mesangial Cells; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta | 2009 |